arrow
M

Monica Barbolini

universita di modena e reggio emilia hospital
H指数:9
被引数:618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study

新辅助帕妥珠单抗、曲妥珠单抗和标准化疗治疗HER2-positive早期乳腺癌的安全性和有效性分析: 来自NeoPowER研究的真实数据

2024-06-151
OAAI
CDK4/6 inhibitors in advanced breast cancer (aBC). Preliminary results of the CDK4/6i choice and sequence of treatments in a series of 174 patients. GOIRC-04-2019 retro/prospective observational study
2024-05-020
PRE
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

新辅助化疗后无病理完全缓解的三阴性乳腺癌患者复发的预测因素

2022-12-019
OAAI